1. Home
  2. DLY vs VSTM Comparison

DLY vs VSTM Comparison

Compare DLY & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Yield Opportunities Fund of Beneficial Interest

DLY

DoubleLine Yield Opportunities Fund of Beneficial Interest

HOLD

Current Price

$14.70

Market Cap

705.8M

Sector

Finance

ML Signal

HOLD

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$6.72

Market Cap

723.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLY
VSTM
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
705.8M
723.8M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
DLY
VSTM
Price
$14.70
$6.72
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$13.38
AVG Volume (30 Days)
215.9K
2.1M
Earning Date
01-01-0001
11-04-2025
Dividend Yield
8.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,379,000.00
Revenue This Year
N/A
$208.54
Revenue Next Year
N/A
$251.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
33.79
52 Week Low
$13.26
$4.01
52 Week High
$15.95
$11.25

Technical Indicators

Market Signals
Indicator
DLY
VSTM
Relative Strength Index (RSI) 52.39 36.02
Support Level $14.67 $6.68
Resistance Level $14.92 $7.26
Average True Range (ATR) 0.09 0.59
MACD 0.01 -0.04
Stochastic Oscillator 53.33 10.29

Price Performance

Historical Comparison
DLY
VSTM

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Share on Social Networks: